About this document
Glimulin MF: Optimal Diabetes Management by kurutala is a document available to read on EtoBox.
Glimulin MF is a first-line therapy for diabetics with an A1C between 7.6-9.0% that offers maximum control and flexibility. It achieves early glycemic control within 12 weeks, improves beta-cell function, and shows a lesser incidence of hypoglycemic events. Glimulin MF significantly reduces fasting and post-prandial blood glucose and offers greater reduction in A1C. It is available as combinations with metformin at 500 mg or 1 g doses to maximize flexibility of treatment.
- Author
- kurutala
- Language
- EN